HK Stock MarketDetailed Quotes


21.000 -0.600-2.78%
Not Open 12/05 16:08 CST


The company is a limited company approved by the National Economic System Reform Commission through Physical Reform [1997] No. 139, initiated exclusively by Guangzhou Pharmaceutical Group Co., Ltd., restructured 8 traditional Chinese medicine manufacturers and 3 pharmaceutical trading enterprises, and established by means of initiation by investing in state-owned assets related to production and operation assets. It is mainly engaged in asset management, investment, development and financing, and is also engaged in the development and production of proprietary Chinese medicines, production of biological products, health medicines, and health drinks, as well as the wholesale, retail, import and export of traditional Chinese medicines, Western medicines and medical devices. The company is mainly engaged in (1) research and development, manufacturing and sales of proprietary Chinese and Western medicines, chemical APIs, natural medicines, biomedicine, and chemical raw drug intermediates; (2) wholesale, retail, import and export of Western medicines, traditional Chinese medicines and medical devices; (3) R&D, production and sales of major health products; and (4) investment in health industries such as medical services, health management, health care and old-age care. The company's main products are thirst quenching pills, Xia Sangju, Wuji Baifeng pills, Huayu recovery pills, honey refined chuanbei loquat cream, Qingkai Ling oral liquid, Xiaochai hu infusion, etc. The main products of Western medicine manufacturers are chemical preparations such as ceftriaxone, etc. The main products of prepackaged food manufacturers are Wang Laoji herbal tea, etc. During the reporting period, the Group and joint ventures obtained a total of 11 production approvals and passed 6 quality regulations for consistency evaluations. A total of 85 patents have been applied for, including 71 invention patents and 14 utility models; 60 authorized patents have been obtained, 40 invention patents have been granted, and 20 utility model patents have been granted.

Company Profile

Listing Date10/30/1997
Issue Price1.65
Shares Offered219.90M share
ChairmanChuyuan Li
SecretaryXuezhen Huang
Audit InstitutionDaishin Certified Public Accountants (Special General Partnership)
Company CategoryMainland registration of Mainland State-owned Assets control
Registered OfficeNo. 45, Shamian North Street, Liwan District, Guangzhou, Guangdong
Head Office and Principal Place of BusinessRoom 2005, 20th floor, Tower 2, Lippo Centre, 89 Queensway, Hong Kong
Fiscal Year Ends12-31
MarketHong Kong motherboard
BusinessState-owned asset management, investment, development and financing; R&D, production and sales: pharmaceuticals, Chinese herbal medicines, Chinese medicine tablets, chemical raw materials, chemical raw materials, chemical raw materials intermediates, chemical raw materials, packaged food, health food, special nutritional food, beverages, medical equipment, pharmaceutical machinery, pharmaceutical products, hygiene materials and dressings, cosmetics, trade brokering and agents (the specific business projects of R&D, production and sales mentioned above are subject to branch licenses); wholesale and retail trade (except for national exclusive control products); providing securities investment, new technology in the pharmaceutical field Products and new materials Technology, product development, technological transformation information, commodity information consulting, property development services; computer software development; information services, technical services; import and export of goods and technology (projects restricted by laws and administrative regulations must be operated after obtaining a license); general freight and freight forwarding; operating countermarketing and re-export trade; warehousing (except chemical dangerous goods); real estate development, property leasing, property management.

Company Executives

  • Name
  • Position
  • Salary
  • Chuyuan Li
  • Chairman,Executive Director,Strategy Committee Chairman,legal representative
  • --
  • Jun Yang
  • Nomination Committee Member,Executive Director,Vice Chairman,Remuneration Committee Member
  • --
  • Ning Cheng
  • Vice Chairman,Executive Director,Authorized Representative
  • --
  • Juyan Liu
  • Executive Director,Strategy Committee Member,Technical Director
  • --
  • Chunbo Zhang
  • Executive Director
  • 300.62K
  • Zhanghai Wu
  • Executive Director,Nomination Committee Member,Remuneration Committee Member
  • 380.31K
  • Hong Li
  • Executive Director,GM,Strategy Committee Member,Party Committee Member
  • 1.50M
  • Yajin Chen
  • Independent Non-Executive Director,Nomination Committee Member,Audit Committee Member,Remuneration Committee Member,Strategy Committee Member
  • 120.00K
  • Min Huang
  • Remuneration Committee Chairman,Nomination Committee Chairman,Independent Non-Executive Director,Audit Committee Member
  • 120.00K
  • Longde Huang
  • Audit Committee Chairman,Independent Non-Executive Director
  • --
  • Baoqing Sun
  • Member of the Strategic Development Committee,Nomination Committee Member,Audit Committee Member,Independent Non-Executive Director
  • --
  • Ruiyu Cai
  • Chairman of the Supervisory Board,Member of the Commission for Discipline Inspection, Director of the Organization Department of the Party Committee, Minister of Human Resources, Minister of United Front Work
  • 1.37M
  • Jinyuan Cheng
  • Shareholders' representatives and supervisors
  • 898.98K
  • Huidong Jian
  • Supervisor
  • 899.52K
  • Haiwen Huang
  • Deputy GM
  • --
  • Haoshan Zheng
  • Deputy GM
  • --
  • Jianxiong Zheng
  • Deputy GM
  • --
  • Xuezhen Huang
  • Company Secretary,Company Secretary
  • --
Paper Trade Start
LMT Order
Claim up to $1 million virtual fund, join moomoo paper trading today! Claim Now >